Medtronic announced the Japanese launch of the Grafton Demineralized Bone Matrix bone grafting product for spine and orthopedic procedures. Grafton DBM is the first and only demineralized bone matrix product available in Japan, the world’s second largest market for spinal medical devices. Due to its long clinical history, proven performance, and safety, Grafton DBM received PMDA approval in August 2018. Grafton DBM is a bone graft extender, bone graft substitute, and bone void filler in bony voids or gaps of the skeletal system. With the proprietary D-MIN process, Grafton consistently scores high osteoinductivity, which is an important part of bone fusion The product is commercially available in the U.S., Japan, Korea, Australia, Latin America, the Middle East, and parts of Europe. Grafton is comprised of multiple forms, each with unique handling characteristics. The product forms launching in Japan include Grafton Putty, Grafton Matrix, and Grafton Matrix Strip.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.